Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Vaxart, Inc. | d453769d8k.htm |
Exhibit 16.1
December 10, 2012
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K dated December 5, 2012, of Biota Pharmaceuticals, Inc. and are in agreement with the statements contained in the second, third and fourth paragraphs on page 2 therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Ernst & Young LLP